Related Experiment Videos
p53 mutations in gastric cancers from Taiwan
L L Hsieh1, J T Hsieh, L Y Wang
1Department of Public Health, Chang Gung College of Medicine and Technology, Taiwan, ROC.
Cancer Letters
|February 27, 1996
Summary
p53 gene mutations are common in gastric cancer, particularly in papillary and intestinal types. These alterations suggest a role for p53 gene mutations in stomach cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 gene is a critical tumor suppressor.
- Gastric cancer is a significant global health concern with diverse subtypes.
Purpose of the Study:
- To investigate the frequency and patterns of p53 gene mutations in primary gastric cancer specimens.
- To determine if p53 mutations are associated with specific histological subtypes of gastric cancer.
Main Methods:
- Analysis of 80 primary gastric cancer surgical specimens.
- Utilized polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) for mutation detection.
- Sequencing to characterize the nature of detected mutations.
Main Results:
- Mutations in the p53 gene were identified in 22.5% (18/80) of gastric tumors.
- Mutations were predominantly found in exons 5, 7, and 8.
- Papillary adenocarcinomas showed a high mutation rate (58.3%), significantly higher than diffuse-type carcinomas (12.5%).
- Intestinal-type gastric carcinomas had a higher prevalence of p53 mutations (37.5%) compared to diffuse-type.
Conclusions:
- p53 gene alterations are frequent in gastric cancer and may play a role in the carcinogenesis of intestinal-type tumors.
- The distribution of mutations suggests specific pathways involved in gastric cancer development.
- The types of mutations (missense, nonsense, transversional) provide insights into mutational processes in gastric cancer.